P
ZNTL icon

Pfizer’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Pfizer’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Hold
953,834
– – 0.84% 12
2025
Q4 		$1.29M Hold
953,834
– – 0.54% 13
2025
Q3 		$1.44M Hold
953,834
– – 0.33% 14
2025
Q2 		$1.11M Hold
953,834
– – 0.19% 15
2025
Q1 		$1.52M Hold
953,834
– – 0.3% 15
2024
Q4 		$2.89M Buy
+953,834
New +$3.13M 0.11% 16

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Pfizer's ZNTL Position: Q1 2026 in Review

Pfizer held its Zentalis Pharmaceuticals (ZNTL) position steady in Q1 2026 at 953,834 shares worth $2M. The position accounts for 0.84% of the portfolio, ranked #12.

Pfizer first reported a position in ZNTL in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.89M in Q4 2024. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

  • Pfizer held 953,834 shares of Zentalis Pharmaceuticals worth $2M as of Q1 2026.
  • Pfizer left its Zentalis Pharmaceuticals share count unchanged in Q1 2026.
  • Zentalis Pharmaceuticals made up 0.84% of Pfizer's portfolio in Q1 2026, its #12 holding.
  • Pfizer first reported a position in Zentalis Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Pfizer's Zentalis Pharmaceuticals position peaked at $2.89M in Q4 2024.
  • 102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on Pfizer's 13F filing for Q1 2026, filed 12 May 2026.